WA
WST icon

Whipplewood Advisors’s West Pharmaceutical WST Stock Holding History

Whipplewood Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.15K Sell
6
-31
-84% -$9.48K ﹤0.01% 413
2026
Q1 		$9.27K Buy
+37
New +$9.21K ﹤0.01% 508
2025
Q3 		– Sell
-39
Closed -$8.53K – 1167
2025
Q2 		$8.53K Sell
39
-222
-85% -$47.5K ﹤0.01% 592
2025
Q1 		$8.73K Buy
261
+186
+248% +$51.3K 0.01% 585
2024
Q4 		$24.6K Buy
+75
New +$23.6K 0.01% 411

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Whipplewood Advisors's WST Position: Q2 2026 in Review

Whipplewood Advisors reduced its West Pharmaceutical (WST) stake by 84% in Q2 2026, selling an estimated $9.48K and leaving 6 shares worth $2.15K. The position accounts for ﹤0.01% of the portfolio, ranked #413.

Whipplewood Advisors first reported a position in WST in Q4 2024 and has held it in 5 quarters since. The position peaked at $24.6K in Q4 2024. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Whipplewood Advisors held 6 shares of West Pharmaceutical worth $2.15K as of Q2 2026.
  • Whipplewood Advisors sold 31 West Pharmaceutical shares in Q2 2026, an estimated $9.48K.
  • West Pharmaceutical made up ﹤0.01% of Whipplewood Advisors's portfolio in Q2 2026, its #413 holding.
  • Whipplewood Advisors first reported a position in West Pharmaceutical in Q4 2024 and has held it in 5 quarters since.
  • Whipplewood Advisors's West Pharmaceutical position peaked at $24.6K in Q4 2024.
  • 834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Whipplewood Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.